Olmutinib
- Generic Name
- Olmutinib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C26H26N6O2S
- CAS Number
- 1353550-13-6
- Unique Ingredient Identifier
- CHL9B67L95
- Background
Olmutinib is an orally active epidermal growth factor receptor inhibitor used in the treatment of T790M mutation positive non-small cell lung cancer. It is available under the brand name Olita made by Hanmi Pharmaceuticals . Olmutinib was developed by Hanmi Pharmaceuticals and Boehringer Ingelheim. Olmutinib recieved breakthrough therapy designation in the U...
- Indication
For use in treatment of metastatic T790M mutation positive non-small cell lung cancer .
- Associated Conditions
- -
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath